+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Interventional Oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product, Application (Liver, Lung, Breast), and End User - Global Forecast to 2025

  • ID: 4826098
  • Report
  • Region: Global
  • 251 Pages
  • Meticulous Market Research Pvt. Ltd.
UP TO OFF
until Dec 31st 2019
1 of 3
Global Interventional Oncology Market to be worth $1,506.3 Million by 2025

FEATURED COMPANIES

  • AngioDynamics Inc.
  • C. R. Bard Inc.
  • EDAP TMS S.A.
  • IceCure Medical Ltd.
  • Medtronic plc
  • Neuwave Medical Inc.
  • MORE

The global interventional oncology market is estimated to grow at a CAGR of 7.7% from 2019 to reach $1,506.3 million by 2025.

Succeeding an extensive secondary and primary research and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, challenges, and opportunities. The factors such as growing preference for minimally invasive treatment procedures, increasing incidence of cancer, rising number of hospitals, and technological advancements in the field of radiology - are driving the growth of global interventional oncology market. However, high cost and risks associated with the interventional oncology procedures and paucity of skilled healthcare professionals hinders the growth of this market.

The global interventional oncology market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by procedure (embolization [TARE, TACE], ablation thermal ablation [microwave, RF ablation]), by product (embolization [SIR-spheres, theraspheres], ablation), application (liver, lung, breast), end-user (hospitals, ambulatory care center), and geography.

The study also evaluates industry competitors and analyzes the market at regional and country level.

Embolization products segment is estimated to command the largest share of the global interventional oncology market in 2019 and expected to witness high growth during the forecast period mainly due to the preference for embolization procedures owing to its benefits such as better clinical outcomes, high specificity & sensitivity towards tumor cells, and efficiency in targeting and detection of tumor lesions. However, the fastest growth in this market is mostly driven by increasing application base of embolization products across various cancer types, rising coverage of reimbursement across the globe, and increasing incidence of cancer & related mortality.

The interventional oncology market for hospitals (end-user segment) is estimated to command the largest share of the global market in 2019. This is attributed to the large volume of patients visiting hospitals for diagnosis & treatment of any healthcare concern including a critical disease like cancer owing to the wide presence, easy accessibility and better healthcare facilities in hospitals.

An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global interventional oncology market, mainly attributed to the factors such as well-established healthcare system including hospitals and ASCs in the North American region, greater adoption of advanced technologies, high level of awareness & spending towards overall healthcare and cancer, growing incidence & prevalence of cancer, presence of key players, and high level of Medicare & Medicaid health insurance coverage.

Key players operating in the global interventional oncology market are Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd.

Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AngioDynamics Inc.
  • C. R. Bard Inc.
  • EDAP TMS S.A.
  • IceCure Medical Ltd.
  • Medtronic plc
  • Neuwave Medical Inc.
  • MORE

1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1. Secondary Research
2.2. Primary Research

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Growing Preference for Minimally invasive Treatment Procedures
4.2.1.2. Increasing Incidence & Prevalence of Cancer
4.2.1.3. Rising Number of Hospitals
4.2.1.4. Technological Advancements in the Field of Radiology
4.2.2. Restraints
4.2.2.1. Potential Risks Associated with Interventional Oncology Procedures
4.2.2.2. High Cost Associated with Interventional Oncology Procedures
4.2.2.3. Paucity of Skilled Healthcare Professionals
4.2.3. Opportunities
4.2.3.1. Significant Growth Opportunities from Emerging Asian and Latin American Markets
4.2.3.2. Introduction of Cloud-Based Medical Imaging
4.2.4. Trend
4.2.4.1. Growing Integration of Image-Guided Solutions with Interventional Oncology Procedures

5. Interventional Oncology Market, by Procedure
5.1. Introduction
5.2. Tumor Embolization
5.2.1. Transarterial Radioembolization (TARE)
5.2.2. Transarterial Chemoembolization (TACE)
5.2.3. Bland Embolization
5.3. Tumor Ablation
5.3.1. Thermal Ablation
5.3.1.1. Radiofrequency Ablation (RFA)
5.3.1.2. Microwave Ablation (MWA)
5.3.1.3. Cryoablation
5.3.1.4. Other Thermal Ablation Procedures
5.3.2. Non-Thermal Ablation

6. Interventional Oncology Market, by Product
6.1. Introduction
6.2. Tumor Embolization
6.2.1. Radioembolic Agents
6.2.1.1. Sir-Spheres
6.2.1.2. TheraSphere
6.2.1.3. QuiremSpheres
6.2.2. Non-Radioactive Embolic Agents
6.2.2.1. Microspheres
6.2.2.2. Particles (PVA Particles and Gelfoam Particles)
6.2.2.3. Drug-Eluting Beads (DEBs)
6.3. Tumor Ablation
6.3.1. Tumor Ablation Devices/Generators
6.3.2. Consumables & Accessories

7. Interventional Oncology Market, by Application
7.1. Introduction
7.2. Liver Cancer
7.3. Lung Cancer
7.4. Breast Cancer
7.5. Prostate Cancer
7.6. Kidney Cancer
7.7. Bone Metastasis
7.8. Other Cancers

8. Interventional Oncology Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Ambulatory Surgery Centres
8.4. Research and Academia

9. Interventional Oncology Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Rest of World
9.5.1. Latin America
9.5.2. Middle East & Africa

10. Competitive Landscape
10.1. Growth Strategies
10.2. Competitive Benchmarking
10.3. Market Share Analysis (2018)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
11.1. Boston Scientific Corporation
11.2. Cook Medical LLC (A Subsidiary of Cook Group)
11.3. Merit Medical Systems, Inc.
11.4. C. R. Bard, Inc. (A Subsidiary of Becton Dickinson & Company)
11.5. Profound Medical Corp.
11.6. AngioDynamics, Inc.
11.7. BTG plc
11.8. Terumo Corporation
11.9. Medtronic plc
11.10. Healthtronics, Inc.
11.11. EDAP TMS S.A.
11.12. Neuwave Medical, Inc. (Subsidiary of Ethicon Inc.)
11.13. Sirtex Medical Limited
11.14. Trod Medical
11.15. Teleflex Incorporated
11.16. IMBiotechnologies Ltd.

12. Appendix
12.1. Questionnaire
12.2. Available Customization

List of Tables
Table 1 Global Interventional Oncology Market Drivers: Impact Analysis (2019-2025)
Table 2 Global Interventional Oncology Market Restraints: Impact Analysis (2019-2025)
Table 3 Cost of Ablation Treatment (For 3cm Kidney Lesion)
Table 4 Global Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 5 Global Tumor Embolization Market Size, by Type, 2017-2025 ($Million)
Table 6 Global Tumor Embolization Market Size, by Country, 2017-2025 ($Million)
Table 7 Global Transarterial Radioembolization Market Size, by Country, 2017-2025 ($Million)
Table 8 Global Transarterial Chemoembolization Market Size, by Country, 2017-2025 ($Million)
Table 9 Global Bland Embolization Market Size, by Country, 2017-2025 ($Million)
Table 10 Global Tumor Ablation Market Size, by Type, 2017-2025 ($Million)
Table 11 Global Tumor Ablation Market Size, by Country, 2017-2025 ($Million)
Table 12 Global Thermal Ablation Market Size, by Type, 2017-2025 ($Million)
Table 13 Global Thermal Ablation Market Size, by Country, 2017-2025 ($Million)
Table 14 Global Radiofrequency Ablation Market Size, by Country, 2017-2025 ($Million)
Table 15 Global Microwave Ablation Market Size, by Country, 2017-2025 ($Million)
Table 16 Global Cryoablation Market Size, by Country, 2017-2025 ($Million)
Table 17 Global Other Thermal Ablation Procedures Market Size, by Country, 2017-2024 ($Million)
Table 18 Global Irreversible Electroporation Market Size, by Country, 2017-2024 ($Million)
Table 19 Global Interventional Oncology Market Size, by Product, 2017-2025 ($Million)
Table 20 Global Tumor Embolization Market Size, by Product Type, 2017-2025 ($Million)
Table 21 Global Tumor Embolization Market Size, by Country, 2017-2025 ($Million)
Table 22 List of Commercialized Radioembolic Agents
Table 23 Global Radioembolic Agents Market Size, by Product, 2017-2025 ($Million)
Table 24 Global Radioembolic Agents Market Size, by Country, 2017-2025 ($Million)
Table 25 Global Non-Radioactive Embolic Agents Market Size, by Type, 2017-2025 ($Million)
Table 26 Global Non-Radioactive Embolic Agents Market Size, by Country, 2017-2025 ($Million)
Table 27 Global Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 28 Global Tumor Ablation Market, by Country, 2017-2025 ($Million)
Table 29 Global Tumor Ablation Devices/ Generators Market Size, by Country, 2017-2025 ($Million)
Table 30 Global Tumor Ablation Consumables & Accessories Market Size, by Country, 2017-2025 ($Million)
Table 31 Global Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 32 Global Interventional Oncology Market Size for Liver Cancer, by Country, 2017-2025 ($Million)
Table 33 Global Interventional Oncology Market Size for Lung Cancer, by Country, 2017-2025 ($Million)
Table 34 Global Interventional Oncology Market Size for Breast Cancer, by Country, 2017-2025 ($Million)
Table 35 Examples of Products Used for Prostate Cancer Treatment
Table 36 Global Interventional Oncology Market Size for Prostate Cancer, by Country, 2017-2025 ($Million)
Table 37 Global Interventional Oncology Market Size for Kidney Cancer, by Country, 2017-2025 ($Million)
Table 38 Global Interventional Oncology Market Size for Bone Metastasis, by Country, 2017-2025 ($Million)
Table 39 Global Interventional Oncology Market Size for Other Cancers, by Country, 2017-2025 ($Million)
Table 40 Global Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 41 Global Interventional Oncology Market Size for Hospitals, by Country, 2017-2025 ($Million)
Table 42 Global Interventional Oncology Market Size for Ambulatory Surgery Centres, by Country, 2017-2025 ($Million)
Table 43 Global Interventional Oncology Market Size for Research and Academia, by Country, 2017-2025 ($Million)
Table 44 Global Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
Table 45 North America: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
Table 46 North America: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 47 North America: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 48 North America: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 49 North America: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 50 North America: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 51 North America: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 52 North America: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 53 North America: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 54 U.S.: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 55 U.S.: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 56 U.S.: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 57 U.S.: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 58 U.S.: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 59 U.S.: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 60 U.S.: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 61 U.S.: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 62 Canada: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 63 Canada: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 64 Canada: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 65 Canada: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 66 Canada: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 67 Canada: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 68 Canada: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 69 Canada: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 70 Europe: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
Table 71 Europe: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 72 Europe: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 73 Europe: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 74 Europe: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 75 Europe: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 76 Europe: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 77 Europe: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 78 Europe: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 79 Germany: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 80 Germany: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 81 Germany: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 82 Germany: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 83 Germany: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 84 Germany: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 85 Germany: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 86 Germany: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 87 France: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 88 France: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 89 France: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 90 France: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 91 France: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 92 France: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 93 France: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 94 France: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 95 U.K.: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 96 U.K.: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 97 U.K.: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 98 U.K.: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 99 U.K.: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 100 U.K.: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 101 U.K.: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 102 U.K.: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 103 Italy: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 104 Italy: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 105 Italy: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 106 Italy: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 107 Italy: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 108 Italy: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 109 Italy: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 110 Italy: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 111 Spain: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 112 Spain: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 113 Spain: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 114 Spain: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 115 Spain: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 116 Spain: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 117 Spain: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 118 Spain: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 119 Interventional Oncology Conferences
Table 120 RoE: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 121 RoE: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 122 RoE: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 123 RoE: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 124 RoE: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 125 RoE: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 126 RoE: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 127 RoE: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 128 Asia-Pacific: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
Table 129 Asia-Pacific: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 130 Asia-Pacific: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 131 Asia-Pacific: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 132 Asia-Pacific: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 133 Asia-Pacific: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 134 Asia-Pacific: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 135 Asia-Pacific: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 136 Asia-Pacific: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 137 Japan: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 138 Japan: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 139 Japan: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 140 Japan: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 141 Japan: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 142 Japan: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 143 Japan: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 144 Japan: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 145 China: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 146 China: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 147 China: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 148 China: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 149 China: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 150 China: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 151 China: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 152 China: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 153 India: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 154 India: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 155 India: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 156 India: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 157 India: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 158 India: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 159 India: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 160 India: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 161 RoAPAC: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 162 RoAPAC: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 163 RoAPAC: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 164 RoAPAC: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 165 RoAPAC: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 166 RoAPAC: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 167 RoAPAC: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 168 RoAPAC: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 169 RoW: Interventional Oncology Market Size, by Region, 2017-2025 ($Million)
Table 170 RoW: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 171 RoW: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 172 RoW: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 173 RoW: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 174 RoW: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 175 RoW: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 176 RoW: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 177 RoW: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 178 Latin America: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 179 Latin America: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 180 Latin America: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 181 Latin America: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 182 Latin America: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 183 Latin America: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 184 Latin America: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 185 Latin America: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 186 Cancer Incidence in Middle East and Africa, 2012-2030 (Number of New Cases)
Table 187 Interventional Oncology Conferences in Middle East & Africa
Table 188 Middle East & Africa: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 189 Middle East & Africa: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 190 Middle East & Africa: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 191 Middle East & Africa: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 192 Middle East & Africa: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 193 Middle East & Africa: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 194 Middle East & Africa: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 195 Middle East & Africa: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 196 Number of Developments by the Major Players During 2016-2019
Table 197 Interventional Oncology: Competitive Benchmarking

List of Figures
Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Tumor Embolization Segment Dominates the Global Interventional Oncology Market
Figure 6 Global Interventional Oncology Market Size, by Application, 2019-2025 ($Million)
Figure 7 Global Interventional Oncology Market, by End User, 2019-2025 ($ Million)
Figure 8 Global Interventional Oncology Market Overview: 2019-2025
Figure 9 Number of Embolization Procedures Performed Globally for Treatment of Liver Cancer, 2016-2027 (In Thousands)
Figure 10 Number of Ablation Procedures Performed Globally, 2016-2027 (In Thousands)
Figure 11 Number of New Cancer Cases Across the Globe, 2012-2040 (In Million)
Figure 12 Cancer Related Deaths Globally, 2012-2040 (Cases in Millions)
Figure 13 Number of Private Hospitals in Australia: 2011-2012 and 2015-2016
Figure 14 Number of Doctors Per 1,000 Population, by Country, 2017
Figure 15 Proportion of Population Aged 60 Or Over in Asia, by Region, 2016-2050
Figure 16 Cancer Incidence in Asia: 2018-2040
Figure 17 Global Interventional Oncology Market Size, by Procedure, 2019-2025 ($Million)
Figure 18 Global Interventional Oncology Market Size, by Product, 2019-2025 ($Million)
Figure 19 Global Sir-Spheres Market Size, 2017-2025 ($Million)
Figure 20 Global TheraSphere Market Size, 2017-2025 ($Million)
Figure 21 Global QuiremSpheres Market Size, 2017-2025 ($Million)
Figure 22 Global Microspheres Market Size, 2017-2025 ($Million)
Figure 23 Global Embolization Particles Market Size, 2017-2025 ($Million)
Figure 24 Global Drug-Eluting Beads Market Size, 2017-2025 ($Million)
Figure 25 Global Interventional Oncology Market Size, by Application, 2019-2025 ($Million)
Figure 26 Number of New Liver Cancer Cases Worldwide (2012-2018)
Figure 27 Number of New Lung Cancer Cases in 2018, by Region (In Thousands)
Figure 28 Number of New Breast Cancer Cases Worldwide, (2012-2018)
Figure 29 Number of New Prostate Cancer Cases Globally, 2018-2030 (In Millions)
Figure 30 Global Incidence of Kidney Cancer, 2012-2018 (Number of Cancer Cases)
Figure 31 U.S: Number of New Stomach Cancer Cases and Related Deaths, 2012-2018
Figure 32 Global Interventional Oncology Market Size, by End User, 2019-2025 ($Million)
Figure 33 Number of Private Hospitals in China, 2013-2017
Figure 34 Number of Outpatient Care Centres in the U.S., 2010-2016
Figure 35 Number of Medicare-Certified Ambulatory Surgical Centres in U.S., 2009-2014
Figure 36 Global Burden of New Cancer Cases Across the World (In Millions)
Figure 37 Global Interventional Oncology Market Size, by Region, 2019-2025 ($Million)
Figure 38 North America: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
Figure 39 Number of New Cancer Cases in the U.S., 2012-2030 (Cases in Million)
Figure 40 Mortality from Cancer in the U.S., 2010-2040 (Number of Deaths Due to Cancer)
Figure 41 Total Cancer Expenditure in the U.S., 2010 & 2017 ($ Billion):
Figure 42 Number of Cancer Cases in Canada: 2017-2030
Figure 43 Total Health Expenditure of Canada, 2000-2017 ($ Billions)
Figure 44 Cancer Cases in Europe (In Millions): 2012-2040
Figure 45 Share of Breast Cancer Screening in Women Aged 50-69 in Europe, by Country, 2016 (%)
Figure 46 Europe: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
Figure 47 Share of Population Aged 65 and Above (As % of total Population), 2011-2018
Figure 48 Cancer Incidence and Mortality in Germany: 2018-2030 (Number of Cases)
Figure 49 Cancer Incidence and Mortality in France: 2018- 2040 (Number of Cases)
Figure 50 Healthcare Spending Per Capita in France, 2011-2017 ($)
Figure 51 Number of New Cancer Cases and Mortality in U.K.:2018-2040
Figure 52 Cost of Cancer Care in the U.K., 2011-2021 ($ Billion)
Figure 53 Cancer Incidence and Mortality in Italy,2018-2035 (Number of Cases)
Figure 54 Population Aged 65 Or Above in Spain (% of total Population
Figure 55 Cancer Incidence and Mortality in Spain, 2018-2040 (Number of Cases)
Figure 56 Cancer Incidence by Country: 2018-2040 (Number of Cases)
Figure 57 Per Capita Health Spending by Country, 2017 (In $PPP)
Figure 58 Asia Cancer Incidence by Region, 2012-2040 (Number of Estimated Cases)
Figure 59 Asia-Pacific: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
Figure 60 Share of Population Aged 65 and Over in Japan, 2000-2030 (% of total Population)
Figure 61 Cancer Incidence and Mortality in Japan, 2018-2040 (Number of Cases)
Figure 62 Number of New Cancer Cases and Related Mortality in China, 2018-2040 (Number of Cases)
Figure 63 Cancer Incidence and Mortality in India, 2018-2030-2040 (Number of Cases)
Figure 64 Proportion of Population Aged 60 Or Above in Asia, by Country, 2015-2030
Figure 65 Age-Adjusted Rate of New Cancer Cases Per 100,000 Population, 2016
Figure 66 Cancer Incidence in RoW, by Country, 2018-2030 (Number of New Cases)
Figure 67 RoW: Interventional Oncology Market Size, by Region, 2019-2025 ($Million)
Figure 68 Cancer Incidence & Related Mortality in Latin America & Caribbean, 2018-2040 (Number of Cases)
Figure 69 Interventional Oncology Conferences in Latin America
Figure 70 Growth Strategies Adopted by Key Players (2016–2019)
Figure 71 Global Interventional Oncology Market Share, by Key Players, 2018 (%)
Figure 72 Boston Scientific Corporation: Financial Overview (2016-2018)
Figure 73 Merit Medical Systems, Inc.: Financial Overview (2016-2018)
Figure 74 Becton, Dickinson, and Company: Financial Overview (2016-2018)
Figure 75 Profound Medical Corp.: Financial Overview (2017-2018)
Figure 76 Angiodynamics, Inc.: Financial Overview (2016-2018)
Figure 77 BTG plc: Financial Overview (2016-2018)
Figure 78 Terumo Corporation: Financial Overview (2016-2018)
Figure 79 Medtronic plc: Financial Overview (2016-2018)
Figure 80 EDAP TMS S.A.: Financial Overview (2016-2018)
Figure 81 Johnson & Johnson: Financial Overview (2016-2018)
Figure 82 Sirtex Medical Limited: Financial Overview (2015-2017)
Figure 83 Teleflex Incorporated: Financial Overview: (2016-2018)

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AngioDynamics Inc.
  • Boston Scientific Corporation
  • BTG plc
  • C. R. Bard Inc.
  • Cook Medical LLC
  • EDAP TMS S.A.
  • HealthTronics Inc.
  • IceCure Medical Ltd.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • MedWaves Inc.
  • Merit Medical Systems Inc.
  • Neuwave Medical Inc.
  • Profound Medical Corp
  • Sanarus Technologies Inc.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical
Note: Product cover images may vary from those shown
Adroll
adroll